Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Product dose omission issue, Pyrexia, Rash, Rash erythematous
Clinical narrative: Cancelled 2nd vaccine shot; electric shock pain shooting in right arm which has moved to right side of abdomen; joint pain in lower extremities where he at times is unable to walk; extremely fatigued; Fever (up to 100.5); chills; Pain in shoulders intensified; shortness of breath; brain fog; non itching red rash from his neck down to his lower extremities/ rash on torso and extrmities continued; bleeding gums; rash on torso and extremities.; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (non itching red rash from his neck down to his lower extremities/ rash on torso and extrmities continued), GINGIVAL BLEEDING (bleeding gums), DYSPNOEA (shortness of breath), DISTURBANCE IN ATTENTION (brain fog) and PAIN (electric shock pain shooting in right arm which has moved to right side of abdomen) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension since 2007 and Urticaria (OCASSIONAL FACIAL SWELLING AND HIVES). Concomitant products included ATORVASTATIN from 30-Nov-2020 to an unknown date for Cholesterol, IRBESARTAN for Hypertension.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced GINGIVAL BLEEDING (bleeding gums) and RASH (rash on torso and extremities.). On 01-Apr-2021, the patient experienced RASH ERYTHEMATOUS (non itching red rash from his neck down to his lower extremities/ rash on torso and extrmities continued). On 20-Apr-2021, the patient experienced DYSPNOEA (shortness of breath), DISTURBANCE IN ATTENTION (brain fog), FATIGUE (extremely fatigued), PYREXIA (Fever (up to 100.5)), CHILLS (chills) and ARTHRALGIA (Pain in shoulders intensified). On 21-Apr-2021, the patient experienced ARTHRALGIA (joint pain in lower extremities where he at times is unable to walk). On 25-Apr-2021, the patient experienced PAIN (electric shock pain shooting in right arm which has moved to right side of abdomen). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Cancelled 2nd vaccine shot). The patient was treated with HYDROXYZINE (oral) ongoing from 27-Apr-2021 at an unspecified dose and frequency; METHYLPREDNISOLONE (oral) on 31-Mar-2021 for Rash, at a dose of 6 days; GABAPENTIN (oral) ongoing from 27-Apr-2021 for  and , at a dose of UNK, tid; GABAPENTIN (oral) ongoing from 27-Apr-2021 for  and , at a dose of UNK, tid; NAPROXEN (NAPROXIN [NAPROXEN]) (oral) ongoing from 27-Apr-2021 at a dose of 250 milligram three times a day; ACETAMINOPHEN (oral) on 27-Apr-2021 at a dose of 500 milligram three times a day; AMBROXOL HYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL ) (oral) on 27-Apr-2021 at a dose of UNK, qd; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) (oral) ongoing from 27-Apr-2021 at a dose of UNK, qd; OXYCODONE (oral) on 27-Apr-2021 at a dose of UNK, bid and PREDNISONE ongoing from 27-Apr-2021 at a dose of 20 mg three times a day. On 03-Apr-2021, GINGIVAL BLEEDING (bleeding gums) had resolved. At the time of the report, RASH ERYTHEMATOUS (non itching red rash from his neck down to his lower extremities/ rash on torso and extrmities continued), DISTURBANCE IN ATTENTION (brain fog), PAIN (electric shock pain shooting in right arm which has moved to right side of abdomen), PYREXIA (Fever (up to 100.5)), CHILLS (chills) and ARTHRALGIA (Pain in shoulders intensified) outcome was unknown, DYSPNOEA (shortness of breath), RASH (rash on torso and extremities.), ARTHRALGIA (joint pain in lower extremities where he at times is unable to walk) and FATIGUE (extremely fatigued) had not resolved and PRODUCT DOSE OMISSION ISSUE (Cancelled 2nd vaccine shot) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Blood test: unknown (normal) normal. On 20-Apr-2021, Blood test: unknown (Inconclusive) Unknown. On 20-Apr-2021, Body temperature: upto 100.5 (Inconclusive) upto 100.5. On 20-Apr-2021, Computerised tomogram: unknown (Inconclusive) unknown. On 23-Apr-2021, Antiphospholipid antibodies negative: unknown (Negative) negative. On 23-Apr-2021, SARS-CoV-2 antibody test: >20 (Inconclusive) >20.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26MAY2021, updated patient demographics, past medical history (Hypertension , asthma, urticaria), lab data, concomitant medications indication for use, treatment medications and additional events. On 23-Jul-2021: Follow up received added Newreporter detail and added new event hypersentivity